These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 2844557

  • 1. Dimerization of neurokinin A and B COOH-terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes.
    Kodama H, Shimohigashi Y, Sakaguchi K, Waki M, Takano Y, Yamada A, Hatae Y, Kamiya H.
    Eur J Pharmacol; 1988 Jul 07; 151(2):317-20. PubMed ID: 2844557
    [Abstract] [Full Text] [Related]

  • 2. Novel ligands confirm NK-1 receptor-mediated modulation of neurotransmission in the guinea pig vas deferens preparation.
    Hall JM, Morton IK.
    Ann N Y Acad Sci; 1991 Jul 07; 632():404-6. PubMed ID: 1719888
    [No Abstract] [Full Text] [Related]

  • 3. A potent and selective agonist for NK-2 tachykinin receptor.
    Rovero P, Pestellini V, Patacchini R, Giuliani S, Santicioli P, Maggi CA, Meli A, Giachetti A.
    Peptides; 1989 Jul 07; 10(3):593-5. PubMed ID: 2550911
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
    Sakaguchi K, Kodama H, Matsumoto H, Yoshida M, Takano Y, Kamiya H, Waki M, Shimohigashi Y.
    Pept Res; 1989 Jul 07; 2(5):345-51. PubMed ID: 2485210
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.
    Stavropoulos G, Karagiannis K, Cordopatis P, Halle D, Gilon C, Bar-Akiva G, Selinger Z, Chorev M.
    Int J Pept Protein Res; 1991 Mar 07; 37(3):180-4. PubMed ID: 1714423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
    Munekata E, Kubo K, Tanaka H, Osakada F.
    Peptides; 1987 Mar 07; 8(1):169-73. PubMed ID: 2437548
    [Abstract] [Full Text] [Related]

  • 11. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM, Flowers JM, Morton IK.
    Br J Pharmacol; 1992 Nov 07; 107(3):777-84. PubMed ID: 1282072
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of novel mammalian tachykinins, neurokinin alpha and neurokinin beta.
    Kimura S, Goto K, Ogawa T, Sugita Y, Kanazawa I.
    Neurosci Res; 1984 Dec 07; 2(1-2):97-104. PubMed ID: 6085651
    [Abstract] [Full Text] [Related]

  • 13. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA, Patacchini R, Eglezos A, Quartara L, Giuliani S, Giachetti A.
    Br J Pharmacol; 1992 Sep 07; 107(1):27-33. PubMed ID: 1384907
    [Abstract] [Full Text] [Related]

  • 14. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity.
    Haro I, Busquets MA, Torres JL, Valencia G, Garcia-Anton JM, Reig F.
    J Pharm Sci; 1990 Jan 07; 79(1):74-6. PubMed ID: 1690289
    [Abstract] [Full Text] [Related]

  • 15. Potent and highly selective neurokinin antagonists.
    Ward P, Ewan GB, Jordan CC, Ireland SJ, Hagan RM, Brown JR.
    J Med Chem; 1990 Jul 07; 33(7):1848-51. PubMed ID: 1694545
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neurokinin receptors antagonists: old and new.
    Jukic D, Rouissi N, Laprise R, Boussougou M, Regoli D.
    Life Sci; 1991 Jul 07; 49(20):1463-9. PubMed ID: 1719324
    [Abstract] [Full Text] [Related]

  • 19. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J, Dion S, D'Orléans-Juste P, Escher E, Drapeau G, Regoli D.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):25-36. PubMed ID: 2417867
    [Abstract] [Full Text] [Related]

  • 20. Effect of newly developed tachykinin agonist and antagonists on the guinea pig isolated gallbladder.
    Patacchini R, Maggi CA.
    J Pharmacol Exp Ther; 1992 Apr 26; 261(1):191-4. PubMed ID: 1313868
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.